L2 Asset Management’s Accendra Health ACH Stock Holding History

L2 Asset Management’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-23,605	Closed	-$2.97K	–	219
2023 Q3	$2.97K	Buy	+23,605	New	+$419K	﹤0.01%	196

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

L2 Asset Management's ACH Position: Q4 2023 in Review

L2 Asset Management sold out of Accendra Health (ACH) in Q4 2023, closing a stake of 23,605 shares — an estimated $2.97K sold.

L2 Asset Management first reported a position in ACH in Q3 2023 and held it in 1 quarter. The position peaked at $2.97K in Q3 2023. 227 funds tracked by Wall St. Rank hold ACH as of Q4 2023.

L2 Asset Management reported no remaining Accendra Health position as of Q4 2023 after selling out during the quarter.
L2 Asset Management sold 23,605 Accendra Health shares in Q4 2023, an estimated $2.97K.
L2 Asset Management first reported a position in Accendra Health in Q3 2023 and held it in 1 quarter.
L2 Asset Management's Accendra Health position peaked at $2.97K in Q3 2023.
227 funds tracked by Wall St. Rank held Accendra Health as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.